• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Alexion, AstraZeneca Rare Disease, Boston, MA

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 5 of 11

  • Page:
  • 1
  • 2
  • 3

Effectiveness of Eculizumab Treatment by Time from Diagnosis in Patients with Generalized Myasthenia Gravis: A Retrospective Electronic Medical Record Analysis

Author:Muppidi, Srikanth   Lee, Justin   Habib, Ali   Howard, James   Klink, Andrew   Kielhorn, Adrian   Sabatella, Guido   Nowak, Richard   

Session Name:S15: Autoimmune Neuromuscular Diseases: New Observations and Therapeutic Approaches  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S15.006  

Author Institution:Stanford Neuroscience Health Center, Stanford, CA  Alexion, AstraZeneca Rare Disease, Boston, MA  University of California, Irvine, Orange, CA  The University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC  Cardinal Health, Philadelphia, PA  Yale University School of Medicine, New Haven, CT  

  • View Abstract
  • View Disclosure

Long-term Efficacy and Safety of Ravulizumab, a Long-acting Terminal Complement Inhibitor, in Adults with Anti-acetylcholine Receptor Antibody-positive Generalized Myasthenia Gravis: Final Results from the Phase 3 CHAMPION MG Open-label Extension

Author:Vu, Tuan   Mantegazza, Renato   Annane, Djillali   Katsuno, Masahisa   Meisel, Andreas   Nicolle, Michael   Bril, Vera   Aguzzi, Rasha   Frick, Glen   Howard, James   

Session Name:S15: Autoimmune Neuromuscular Diseases: New Observations and Therapeutic Approaches  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S15.010  

Author Institution:University of South Florida Morsani College of Medicine, Tampa, FL  Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy  Hôpital Raymond Poincaré, Garches, France  Nagoya University Graduate School of Medicine, Nagoya, Japan  Charité Universitätsmedizin Berlin, Berlin, Germany  London Health Sciences Centre, London, ON, Canada  University of Toronto, Toronto, ON, Canada  Alexion, AstraZeneca Rare Disease, Boston, MA  The University of North Carolina, Chapel Hill, NC  

  • View Abstract
  • View Disclosure

Efficacy and Safety of Ravulizumab in Adults With Anti-Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder (AQP4+ NMOSD): Interim Analysis From the Ongoing Phase 3 CHAMPION-NMOSD Trial

Author:Pittock, Sean   Barnett, Michael   Bennett, Jeffrey   Berthele, Achim   De Seze, Jerome   Levy, Michael   Nakashima, Ichiro   Oreja-Guevara, Celia   Palace, Jacqueline   Paul, Friedemann   Pozzilli, Carlo   Mashhoon, Yasmin   Allen, Kerstin   Parks, Becky   Kim, Ho Jin   

Session Name:S32: Autoimmune Neurology: NMOSD/MOGAD  

Topic:Autoimmune Neurology  

Program Number:S32.003  

Author Institution:Mayo Clinic, Rochester, MN  University of Sydney, Camperdown, Australia  University of Colorado, Aurora, CO  School of Medicine, Technical University Munich, Munich, Germany  Strasbourg University Hospital Center, Strasbourg, France  Massachusetts General Hospital/Harvard Medical School, Boston, MA  Tohoku Medical and Pharmaceutical University, Sendai, Japan  San Carlos Clinical Hospital and Complutense University of Madrid, Madrid, Spain  John Radcliffe Hospital, Oxford, United Kingdom  Charité-Universitätsmedizin Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany  Sapienza University, Rome, Italy  Alexion, AstraZeneca Rare Disease, Boston, MA  National Cancer Center, Goyang, Korea, Republic of  

  • View Abstract
  • View Disclosure

Evaluation of Glial Fibrillary Acidic Protein (GFAP) and Neurofilament Light Chain (NfL) Levels During Eculizumab and Ravulizumab Treatments in Aquaporin-4-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD)

Author:Wingerchuk, Dean   Bennett, Jeffrey   Berthele, Achim   Clardy, Stacey   Kim, Ho Jin   Nakahara, Jin   De Seze, Jerome   Kinoshita, Makoto   Bou-Chahine, Ruba Deeb   Mashhoon, Yasmin   Parks, Becky   Allen, Kerstin   Thakar, Ketan   Carlin, Dan   Stankowski, Jeannette   Pittock, Sean   

Session Name:S32: Autoimmune Neurology: NMOSD/MOGAD  

Topic:Autoimmune Neurology  

Program Number:S32.004  

Author Institution:Mayo Clinic, Phoenix, Scottsdale, AZ  University of Colorado School of Medicine, Aurora, CO  School of Medicine, Technical University Munich, Muenchen, Germany  University of Utah, Salt Lake City, UT  National Cancer Center, Goyang, Korea, Republic of  Keio University School of Medicine, Shinjuku-ku, Japan  CHU de Strasbourg, Strasbourg, France  Osaka General Medical Center, Osaka, Japan  Alexion, AstraZeneca Rare Disease, Boston, MA  Mayo Clinic, Rochester, Rochester, MN  

  • View Abstract
  • View Disclosure

Rates of Myasthenic Crisis, Exacerbation and Healthcare Resource Utilization in Eculizumab-treated Patients with Generalized Myasthenia Gravis in a Global Registry

Author:Tandan, Rup   Cutter, Gary   Winkley, James   Greene, Ericka   Rodrigues, Ema   Sabatella, Guido   Macwan, Samir   

Session Name:S38: Autoimmune Neurology: Peripheral Autoimmunity, Paraneoplastic Disease, Checkpoint Inhibitors, and Neurosarcoidosis  

Topic:Autoimmune Neurology  

Program Number:S38.001  

Author Institution:Myasthenia Gravis Center, University of Vermont Medical Center, Burlington, VT  Department of Biostatistics, University of Alabama at Birmingham School of Public Health, Birmingham, AL  Baptist Health Louisville, Nicholasville, KY  Stanley H Appel Department of Neurology, Houston Methodist Hospital, Houston, TX  Alexion, AstraZeneca Rare Disease, Boston, MA  Alexion, AstraZeneca Rare Disease, Reading, MA  Eisenhower Health, Rancho Mirage, CA  

  • View Abstract
  • View Disclosure

Displaying 1 - 5 of 11

  • Page:
  • 1
  • 2
  • 3

© 2015 Mira Smart Conference | http://www.mirasmart.com